Cargando…

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients

Fibrosis of oesophagus, lungs, heart, and kidney in the course of systemic sclerosis (SSc) may lead to dysfunction of the above organs or even patients death. Recent studies point out the role of angiogenesis and fibrosis disturbances in the pathogenesis of SSc. Heart fibrosis is one of the most imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dziankowska-Bartkowiak, Bożena, Waszczykowska, Elżbieta, Zalewska, Anna, Sysa-Jędrzejowska, Anna
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2005
Materias:	Research Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526474/ https://www.ncbi.nlm.nih.gov/pubmed/16106100 http://dx.doi.org/10.1155/MI.2005.144

Ejemplares similares

Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement.
por: Dziankowska-Bartkowiak, Bozena, et al.
Publicado: (2003)

The Imbalance Between Metalloproteinases and Their Tissue Inhibitors Is Involved in the Pathogenesis of Dermatitis Herpetiformis
por: Zebrowska, Agnieszka, et al.
Publicado: (2005)

Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2011)

Prevalence of ocular manifestations in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2013)

Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2014)

Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis
por: Poliwczak, Adam R., et al.
Publicado: (2019)

Chronic mucocutaneous candidiasis with endocrinopathy – case report
por: Lesiak, Aleksandra, et al.
Publicado: (2010)

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Circulating angiostatin serum level in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2017)

ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2018)

Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients—one-year follow-up study
por: Waszczykowski, Michał, et al.
Publicado: (2021)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

Expression of Selected Integrins and Selectins in Bullous Pemphigoid
por: Żebrowska, Agnieszka, et al.
Publicado: (2007)

The Expression of Selected Proapoptotic Molecules in Dermatitis Herpetiformis
por: Agnieszka, Zebrowska, et al.
Publicado: (2012)

IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid
por: Zebrowska, Agnieszka, et al.
Publicado: (2013)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.
por: Waszczykowska, E, et al.
Publicado: (1999)

Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients
por: Groblewska, Magdalena, et al.
Publicado: (2014)

Atypical clinical presentation of lichen planus bullous in a systemic sclerosis patient
por: Gerlicz-Kowalczuk, Zofia A., et al.
Publicado: (2016)

Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury
por: Chen, Guobing, et al.
Publicado: (2020)

Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer
por: Kaczorowska, Aleksandra, et al.
Publicado: (2020)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Interleukin 6 and 8 Levels in Plasma and Fibroblast Cultures in Psoriasis
por: Zalewska, Anna, et al.
Publicado: (2006)

Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion
por: Di Gregoli, Karina, et al.
Publicado: (2016)

Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain
por: Łukomska, Agnieszka, et al.
Publicado: (2020)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
por: Okazaki, Isao, et al.
Publicado: (2014)

Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (1999)

Behçet's disease leaves the silk road
por: Woźniacka, Anna, et al.
Publicado: (2014)

The use of isotretinoin in low doses and unconventional treatment regimens in different types of acne: a literature review
por: Torzecka, Jolanta D., et al.
Publicado: (2017)

Quality of life and satisfaction with life in SLE patients—the importance of clinical manifestations
por: Kulczycka, Lilianna, et al.
Publicado: (2010)

Topical steroid therapy in atopic dermatitis in theory and practice
por: Jeziorkowska, Renata, et al.
Publicado: (2015)

Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
por: Joo, Y. E., et al.
Publicado: (1999)

Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma
por: Joo, Young-Eun, et al.
Publicado: (2000)

Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology
por: Fan, Dong, et al.
Publicado: (2020)

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
por: Becher, Naja, et al.
Publicado: (2008)

Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023)

Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes
por: Batra, Jyotica, et al.
Publicado: (2013)

Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta
por: Kuźnik-Trocha, Kornelia, et al.
Publicado: (2020)

Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis
por: Bogaczewicz, Jarosław, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bp4vedmed43iq1r3ufceurl32r